Chen, J. J., Liu, Q., Yuan, C., Gore, V., Lopez, P., Ma, V., Amegadzie, A., Qian, W., Judd, T. C., Minatti, A. E., Brown, J., Cheng, Y., Xue, M., Zhong, W., Dineen, T. A., Epstein, O., Human, J., Kreiman, C., Marx, I., Weiss, M. M., Hitchcock, S. A., Powers, T. S., Chen, K., Wen, P. H., Whittington, D. A., Cheng, A. C., Bartberger, M. D., Hickman, D., Werner, J. A., Vargas, H. M., Everds, N. E., Vonderfecht, S. L., Dunn, R. T., Wood, S., Fremeau, R. T., White, R. D., & Patel, V. F. (2015). development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease. Bioorganic & medicinal chemistry letters, 25(4), 767–774. http://access.bl.uk/ark:/81055/vdc_100025862588.0x00004b